---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-001518"
form_type: "8-K"
ticker: "VCEL"
cik: "0000887359"
company_name: "Vericel Corp"
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:46:36.452634+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vericel reports preliminary FY2023 revenue ~$197.5M (+20% YoY); Q4 revenue $65M (+23%)

## Summary
- FY2023 preliminary total revenue ~$197.5M (+20% YoY); MACI revenue ~$164.8M (+25%); Burn Care revenue ~$32.7M.
- Q4 2023 revenue ~$65M (+23% YoY); MACI $56.7M (+22%); Burn Care $8.3M (+31%); gross margin >70%.
- Record-high Q4 MACI implants, implanting surgeons, biopsies, and biopsies since launch; highest Epicel biopsies since 2021.
- Cash, restricted cash & investments ~$152M, no debt; adjusted EBITDA margin ~30% in Q4, mid-teens for full year.
- NexoBrid U.S. launch underway with >50 burn centers submitted to P&T committees; arthroscopic MACI launch expected later in 2024.

## SEC filing metadata
- accession: 0001140361-24-001518
- form_type: 8-K
- ticker: VCEL
- cik: 0000887359
- company_name: Vericel Corp
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887359/000114036124001518/0001140361-24-001518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887359/000114036124001518/ef20018464_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-001518
- JSON: https://secwatch.observer/filing/0001140361-24-001518.json
- Plain text: https://secwatch.observer/filing/0001140361-24-001518.txt

## Key facts
- Earnings Releases
  Vericel Corp reported the fourth quarter and year ended December 31, 2023 results: revenue Total net revenue expected to be approximately $197.5 million.
  - Period: the fourth quarter and year ended December 31, 2023
  - Revenue: Total net revenue expected to be approximately $197.5 million
  - Result: preliminary results
  source text: Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results Full-Year Total Revenue Expected to be Approximately $197.5 Million
  evidence_url: https://www.sec.gov/Archives/edgar/data/887359/000114036124001518/0001140361-24-001518-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.